The union cabinet on Thursday approved $750 million (Rs.4,944 crore) investment by Dutch drug major Mylan Group B.V. Netherlands into its Indian subsidiary Mylan Laboratories Ltd.
The union cabinet on Thursday approved $750 million (Rs.4,944 crore) investment by Dutch drug major Mylan Group B.V. Netherlands into its Indian subsidiary Mylan Laboratories Ltd.
Taking Vitamin D supplements could prevent the development of heart disease in chronic kidney disease patients.
Adolescent exposre to organochlorine pesticides such as DDT may lead to defective sperm and consequently fertility problems later in life, says a study.
Widely thought to be essential for good health, Omega 3 fatty acid supplements may not be of much help in treating major depressive disorders, suggests new research.
Premature ejaculation including female sexual dysfunction should not be classified as an illness, argue researchers, adding that the illness factor may have been constructed by sexual medicine experts under the influence of drug companies.
Once they enter memory, depressive thoughts can linger for long in affected people, and this extended duration may reduce the amount of information that these individuals can remember, suggests new research.
[adsense:336x280:8701650588]
Like HIV and Ebola, the hepatitis A virus is of likely animal origin, finds a large-scale study looking into the evolutionary origins of the global pathogen.
Particulate matter and nitric dioxide emissions from industrial plants or vehicles increase the risk of heart attacks, despite being within 'safe' levels of air pollution, a new study has claimed. The study examined the effect of short term exposure to air pollution on the risk of ST-segment elevation myocardial infarction (STEMI). This type of myocardial infarction (heart attack) has the worst prognosis and is caused by thrombotic occlusion of a coronary artery that damages the heart.
Cow & Gate, a baby food company is recalling a batch of its 'Sunny Start My First Banana Muesli' packs after receiving complaints of insects found in it.
The INSPIRE consortium, led by Videregen Ltd, has received approval from the MHRA to start a UK clinical trial with its tissue engineered replacement trachea. The trial, which is expected to start in the first half of 2016, will focus on severe structural airway disease (SSAD), a potentially life-threatening condition believed to affect 19,000 people in Europe and the US. Along with Videregen as commercial partner, the consortium includes the Cell Therapy Catapult, University College London (UCL), NHS Blood and Transplant in Speke and the Royal Free London NHS Foundation Trust.